The arrival of the COVID-19 pandemic in my French region and also in Grenoble has radically changed how teaching classes have been organised in our Grenoble Alpes University Medical School. To better explain these changes, I need to illustrate how… Continue Reading

Read reports from two fellows who completed their fellowships in FRance in 2019 and 2020.

For 2020, we have selected: Shahnawaz M, Mukherjee A, Pritzkow S et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy.

As any place in Europe and beyond, the French health system is still under pressure and Covid-19 has already and will profoundly change healthcare.

As soon as the dramatic developments in our European fellow countries Italy, France, and Spain came to our attention, an emergency plan was deployed across the country. Besides coordinating logistics of allocating protection gear and respirators, all hospitals with the respective competence and resources in intensive care medicine have systematically ramped up their capacities.

Giovanni Di Liberto, MD-PhD Chair, RRFS – Residents and Research Fellows Section of the EAN Dr. Thomas Jenkins, Chair of the EAN e-Communication Committee interviews: Dear Dr. Di Liberto, You recently took over the leadership of the RRFS EAN section.… Continue Reading

New gene therapy to treat spinal muscular atrophy On March 27, European Medicines Agency (EMA) recommended granting a conditional marketing authorisation in the European Union for the gene therapy Zolgensma (onasemnogene abeparvovec) to treat babies and young children with spinal… Continue Reading

Discussions during last year’s Spring Meeting and General Assembly showed that BioMed Alliance Members are affected by Plan S. Due to COVID-19, adaptation to the open access initiative within the foreseen timeline has become even more challenging for medical societies.… Continue Reading

EMA has published its Regulatory Science Strategy to 2025 today. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It comes in response to the dramatic acceleration of the… Continue Reading

Despite some positive slowing of new cases and deaths in some countries, the COVID-19 pandemic has infected until today over 3.5 million people, leading to more than 250,000 deaths across the globe. Without a doubt, the crisis sparked by this pandemic has also wreaked havoc on healthcare systems and economies while causing massive disruption to the everyday lives of people around the world.